Pure Red Cell Aplasia Induced by Atezolizumab in a Patient with Small-Cell Lung Cancer Successfully Treated with Steroid Therapy: A Case Report

Introduction: Combination therapy of atezolizumab and chemotherapy has become the standard treatment for small-cell lung cancer. Immune-related adverse events (irAEs) can occur during immune checkpoint inhibitor administration. A few reports exist on pure red cell aplasia (PRCA) as an irAE after ate...

Full description

Bibliographic Details

Published in:	Case Reports in Oncology
Main Authors:	Keita Kawakado, Shunsuke Ito, Kento Kono, Yuki Mitarai, Takashi Yanagawa, Makoto Nagasaki
Format:	Article
Language:	English
Published:	Karger Publishers 2023-12-01
Subjects:	pure red cell aplasia atezolizumab small-cell lung cancer
Online Access:	https://beta.karger.com/Article/FullText/535468